Solving for nuclear structure in light nuclei
Saori Pastore, assistant professor of physics in Arts & Sciences at Washington University in St. Louis, helps explain what happens in nuclei when they decay, scatter among each other or come into contact with subatomic particles. Her recent paper, “Weak Transitions in Light Nuclei,” published in Frontiers in Physics, contributes to a body of increasingly accurate, descriptive calculations of nuclear structure and reactions.
Lethal brain infections in mice thwarted by decoy molecule
School of Medicine scientists have identified a molecule that protects mice from brain infections caused by Venezuelan equine encephalitis virus, a mosquito-borne virus notorious for causing fast-spreading, deadly outbreaks in Mexico, Central America and northern South America.
Widening income gap means less grocery variety for all
Even before COVID-19 and resulting shutdowns created gridlock for some global supply chains, the assortment at many neighborhood supermarkets was dwindling. The cause was not a lack of supply, though, but rather a lack of demand created by a widening income gap in the U.S., according to a new study involving a Washington University in St. Louis researcher.
Quantum tunneling pushes the limits of self-powered sensors
Using quantum tunneling, the lab of Shantanu Chakrabartty, at the McKelvey School of Engineering at Washington University in St. Louis, has developed self-powered sensors that can run for more than a year.
Recruiting during a pandemic
The Class of 2025 at Washington University in St. Louis will be talented, driven and diverse — of this Ronné Turner, vice provost for admissions and financial aid, is certain. But the hard work of recruiting and admitting students during this unprecedented admission cycle won’t be easy. Turner and Emily Almas, director of admissions, discuss how the pandemic has changed the admissions landscape.
Study: Respiratory failure in COVID-19 usually not driven by cytokine storm
A study led by School of Medicine researchers showed that, contrary to expectations, most people with severe COVID-19 do not suffer from unbridled inflammation. The findings suggest that anti-inflammatory therapies may not be helpful for most COVID-19 patients.
Fluvoxamine may prevent serious illness in COVID-19 patients
Researchers at Washington University School of Medicine have found that the drug fluvoxamine may help prevent deterioration in COVID-19 patients, making hospitalization less likely.
The vexing vax supply chain
The cold, hard fact is: Pfizer blazed a trail in creating a touted COVID-19 vaccine, but now it must help to equally pioneer an unprecedented way to distribute the drug across the United States and the globe, says a supply chain expert at Washington University in St. Louis.
Pollution and pandemics: A dangerous mix
Research from the lab of Rajan Chakrabarty in the McKelvey School of Engineering at Washington University in St. Louis has found a close relationship between certain pollutants and the spread of COVID-19 through the United States.
Making cancer cells more susceptible to dying
Cancer cells can survive even after being hit with high doses of chemotherapy or radiation, but a School of Medicine team working to make treatment more effective is focusing on ways to tweak the inner machinery of cancer cells to make them more susceptible to dying.
View More Stories